This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.
Here is a sample of this item:
by Mike Caswell
Emerald Health Therapeutics Inc.'s president, Bin Huang, has reached an out-of-court deal to settle a lawsuit she faced in the Supreme Court of British Columbia over a stock option. A privately held entity had claimed that it was entitled to an option for 830,000 shares as part of a finder's fee arrangement. The option was supposedly exercisable at 10 cents, which would have made it of some value.
The end of the lawsuit is contained in a consent order filed at the Vancouver courthouse on Oct. 26, 2017. The order simply states that the suit is dismissed with each side to bear its own legal costs. Lawyers for both sides signed the document.
The order brings a quiet end to a case that began almost a year ago. On Nov. 30, 2016, privately held Jescorp Capital Inc. filed a notice of claim against Ms. Huang. According to the suit, Jescorp acted as a finder in a May, 2015, transaction between Emerald Health and a company called Medna Biosciences Inc. (The suit had no details of the transaction, but that month Medna acquired 20.15 million shares of an Emerald predecessor.)
The remainder is available to Stockwatch subscribers.
© 2018 Canjex Publishing Ltd. All rights reserved.